US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist
  • 0.007140
  • -0.000360-4.80%
15min DelayClose Jul 3 12:55 ET
222.14KMarket Cap0.01P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
(Q3)May 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-571.26%-124.4K
25.09%-71.85K
93.30%-112.52K
113.72%20.52K
95.05%-18.59K
94.82%-18.53K
87.96%-95.92K
32.64%-1.68M
74.30%-149.51K
39.08%-375.36K
Net income from continuing operations
87.60%-325.46K
50.09%-178.52K
0.35%-3.71M
-19.56%-573.55K
77.31%-154.69K
-111.83%-2.62M
72.97%-357.67K
-16.55%-3.72M
29.57%-479.71K
48.51%-681.65K
Depreciation and amortization
-18.65%32.86K
-8.62%39.46K
-18.37%162.06K
-18.60%38.49K
-18.09%39.99K
-20.16%40.39K
-16.67%43.19K
-10.14%198.53K
-7.23%47.29K
-12.72%48.83K
Other non cash items
-94.62%129.06K
152.17%11.45K
292.01%2.78M
4,306.25%376.71K
-100.00%-1
--2.4M
--4.54K
30.25%709.44K
-113.15%-8.96K
-93.75%40K
Change In working capital
-69.27%74.12K
-84.99%20.79K
16.43%474.13K
-27.54%143.89K
-143.90%-49.4K
413.58%241.17K
181.75%138.47K
735.76%407.23K
1,106.71%198.58K
824.94%112.54K
-Change in receivables
-438.19%-57.49K
842.43%25.32K
-111.20%-13.84K
268.20%210.03K
-908.01%-243.56K
66.42%17K
-89.75%2.69K
1,286.44%123.6K
1,494.01%57.04K
151.86%30.14K
-Change in payables and accrued expense
-45.74%61.66K
-103.34%-4.53K
72.05%487.97K
-146.73%-66.14K
269.79%304.69K
209.27%113.64K
491.81%135.78K
628.80%283.62K
1,005.33%141.54K
41,304.52%82.4K
Cash from discontinued investing activities
Operating cash flow
-571.26%-124.4K
25.09%-71.85K
93.30%-112.52K
113.72%20.52K
95.05%-18.59K
94.82%-18.53K
87.96%-95.92K
32.64%-1.68M
74.30%-149.51K
39.08%-375.36K
Investing cash flow
Cash flow from continuing investing activities
-19.03%20K
-1.2K
-2.09%24.7K
0
0
24.7K
0
-96.09%25.23K
25.74K
0
Net PPE purchase and sale
--0
---1.2K
--0
--0
--0
--0
--0
2,775.40%25.23K
--25.74K
--0
Net investment purchase and sale
----
----
--24.7K
--0
--0
----
----
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-19.03%20K
---1.2K
-2.09%24.7K
--0
--0
--24.7K
--0
-96.09%25.23K
--25.74K
--0
Financing cash flow
Cash flow from continuing financing activities
0
24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
19.98K
0
-84.13%389.86K
149.86K
-80.80%240K
Net issuance payments of debt
--0
--24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
--19.98K
--0
-84.13%389.86K
--149.86K
-80.80%240K
Cash from discontinued financing activities
Financing cash flow
--0
--24.99K
-74.35%100K
-56.61%65.03K
-93.75%14.99K
--19.98K
--0
-84.13%389.86K
--149.86K
-80.80%240K
Net cash flow
Beginning cash position
278.00%81.65K
10.37%129.7K
-91.52%117.52K
-54.14%44.15K
-79.39%47.75K
-97.25%21.6K
-91.52%117.52K
78.30%1.39M
-95.15%96.28K
-82.64%231.64K
Current changes in cash
-499.26%-104.4K
49.90%-48.05K
100.96%12.18K
227.88%85.55K
97.34%-3.6K
104.71%26.15K
84.02%-95.92K
-307.62%-1.26M
104.35%26.09K
-120.76%-135.36K
Effect of exchange rate changes
----
----
--0
--0
--0
----
----
---4.85K
---4.85K
----
End cash Position
-22.21%37.14K
278.00%81.65K
10.37%129.7K
10.37%129.7K
-54.14%44.15K
-79.39%47.75K
-97.25%21.6K
-91.52%117.52K
-91.52%117.52K
-95.15%96.28K
Free cash flow
-571.26%-124.4K
23.85%-73.04K
93.31%-112.52K
113.62%20.52K
95.05%-18.59K
94.83%-18.53K
87.96%-95.92K
32.60%-1.68M
74.11%-150.65K
39.08%-375.36K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022(Q3)May 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -571.26%-124.4K25.09%-71.85K93.30%-112.52K113.72%20.52K95.05%-18.59K94.82%-18.53K87.96%-95.92K32.64%-1.68M74.30%-149.51K39.08%-375.36K
Net income from continuing operations 87.60%-325.46K50.09%-178.52K0.35%-3.71M-19.56%-573.55K77.31%-154.69K-111.83%-2.62M72.97%-357.67K-16.55%-3.72M29.57%-479.71K48.51%-681.65K
Depreciation and amortization -18.65%32.86K-8.62%39.46K-18.37%162.06K-18.60%38.49K-18.09%39.99K-20.16%40.39K-16.67%43.19K-10.14%198.53K-7.23%47.29K-12.72%48.83K
Other non cash items -94.62%129.06K152.17%11.45K292.01%2.78M4,306.25%376.71K-100.00%-1--2.4M--4.54K30.25%709.44K-113.15%-8.96K-93.75%40K
Change In working capital -69.27%74.12K-84.99%20.79K16.43%474.13K-27.54%143.89K-143.90%-49.4K413.58%241.17K181.75%138.47K735.76%407.23K1,106.71%198.58K824.94%112.54K
-Change in receivables -438.19%-57.49K842.43%25.32K-111.20%-13.84K268.20%210.03K-908.01%-243.56K66.42%17K-89.75%2.69K1,286.44%123.6K1,494.01%57.04K151.86%30.14K
-Change in payables and accrued expense -45.74%61.66K-103.34%-4.53K72.05%487.97K-146.73%-66.14K269.79%304.69K209.27%113.64K491.81%135.78K628.80%283.62K1,005.33%141.54K41,304.52%82.4K
Cash from discontinued investing activities
Operating cash flow -571.26%-124.4K25.09%-71.85K93.30%-112.52K113.72%20.52K95.05%-18.59K94.82%-18.53K87.96%-95.92K32.64%-1.68M74.30%-149.51K39.08%-375.36K
Investing cash flow
Cash flow from continuing investing activities -19.03%20K-1.2K-2.09%24.7K0024.7K0-96.09%25.23K25.74K0
Net PPE purchase and sale --0---1.2K--0--0--0--0--02,775.40%25.23K--25.74K--0
Net investment purchase and sale ----------24.7K--0--0----------0--0--0
Cash from discontinued investing activities
Investing cash flow -19.03%20K---1.2K-2.09%24.7K--0--0--24.7K--0-96.09%25.23K--25.74K--0
Financing cash flow
Cash flow from continuing financing activities 024.99K-74.35%100K-56.61%65.03K-93.75%14.99K19.98K0-84.13%389.86K149.86K-80.80%240K
Net issuance payments of debt --0--24.99K-74.35%100K-56.61%65.03K-93.75%14.99K--19.98K--0-84.13%389.86K--149.86K-80.80%240K
Cash from discontinued financing activities
Financing cash flow --0--24.99K-74.35%100K-56.61%65.03K-93.75%14.99K--19.98K--0-84.13%389.86K--149.86K-80.80%240K
Net cash flow
Beginning cash position 278.00%81.65K10.37%129.7K-91.52%117.52K-54.14%44.15K-79.39%47.75K-97.25%21.6K-91.52%117.52K78.30%1.39M-95.15%96.28K-82.64%231.64K
Current changes in cash -499.26%-104.4K49.90%-48.05K100.96%12.18K227.88%85.55K97.34%-3.6K104.71%26.15K84.02%-95.92K-307.62%-1.26M104.35%26.09K-120.76%-135.36K
Effect of exchange rate changes ----------0--0--0-----------4.85K---4.85K----
End cash Position -22.21%37.14K278.00%81.65K10.37%129.7K10.37%129.7K-54.14%44.15K-79.39%47.75K-97.25%21.6K-91.52%117.52K-91.52%117.52K-95.15%96.28K
Free cash flow -571.26%-124.4K23.85%-73.04K93.31%-112.52K113.62%20.52K95.05%-18.59K94.83%-18.53K87.96%-95.92K32.60%-1.68M74.11%-150.65K39.08%-375.36K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg